Biểu đồ giá cổ phiếu BIAF
BIAF Giá
bioAffinity Technologies Inc
$2.03
-4.24%
$-0.09
Khi đóng cửa: May 08, 16:00:00 GMT-4
$1.94
-4.43%
$-0.08
Phiên sau giờ: May 08, 20:00:00 GMT-4
Quay lại
bioAffinity Technologies Inc (BIAF) Giá
Thống kê chính
Giá đóng cửa trước
$2.12
Giá mở cửa
$2.07
Phạm vi ngày
$1.94 - $2.12
Phạm vi 52 tuần
$0.693 - $17.43
Khối lượng
161.9K
Khối lượng trung bình
8.9M
Tỷ suất cổ tức
--
EPS (TTM)
-15.42
Vốn hóa thị trường
$8.7M
BIAF là gì?
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The company is headquartered in San Antonio, Texas. The company went IPO on 2022-08-26. The company develops noninvasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis developed by machine learning, a form of artificial intelligence (AI). The Company’s product, CyPath Lung, is a noninvasive test that has shown high sensitivity, specificity and accuracy for the detection of early-stage lung cancer. CyPath is marketed as a Laboratory Developed Test (LDT) by Precision Pathology Laboratory Services, a subsidiary of the Company. CyPath Lung uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor.
